You searched for "optical"
EGS: 18th EGS Residents' Course
European Glaucoma SocietyMoorfields International refractive symposium
The Moorfields International refractive symposium covers contemporary vision correction surgery to surgeons in the UK and around the world. Taking place on Thursday 24 April at the Royal College of Physicians in London (08:30 - 17:45), the symposium aims to...Conference Report: The Medical Ophthalmology Society UK (MOSUK) 26th Annual Meeting
The Medical Ophthalmology Society UK (MOSUK) held its 26th annual meeting on 26 February 2025 at the International Students House in Great Portland Street, London. Medical ophthalmology is a distinctive and holistic speciality that encompasses the investigation, diagnosis, and management...
Use of technology in low vision rehabilitation
This article is a review of the accessibility features available on tablets and smartphones for the visually impaired. It explains exactly what the accessibility features are, how to access them and how to use them as well as some useful...Easter Weekend sees the start of Innovia Face Visor production
Innovia Medical Group has announced that production of its Innovia Face Visor is now underway.
Retinal pigment epithelium tears
In this paper the authors review the current knowledge of retinal pigment epithelium (RPE) tears. Although rare these can cause loss of visual acuity. They can occur spontaneously in pigment epithelial detachment (PED) due to occult choroidal neovascularisation (CNV), retinal...
IVTA for diabetic macular edema and macular edema secondary to retinal vein occlusion: a meta-analysis
This meta-analysis aimed to compare the safety and efficacy of different doses of intravitreal triamcinolone acetonide (IVTA) for diabetic macular oedema (DME) and macular oedema (ME) secondary to retinal vein occlusion (RVO). A systematic literature search for randomised controlled trials...Vabysmo receives NICE approval
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...
